Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022003541 - TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL

Publication Number WO/2022/003541
Publication Date 06.01.2022
International Application No. PCT/IB2021/055772
International Filing Date 28.06.2021
IPC
A61K 31/05 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61P 25/22 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
Applicants
  • ZYNERBA PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • GRIESSER, John
  • DOBBINS, Thomas W.
  • SEBREE, Terri
Agents
  • HANRAHAN, Benedict L.
  • HERRITT, Danielle L.
Priority Data
63/045,66429.06.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL
(FR) TRAITEMENT DU SYNDROME DE L'X FRAGILE AU MOYEN DE CANNABIDIOL
Abstract
(EN) The present technology relates to a method of treating one or more symptoms of Full Methylation (Fmet) Fragile X Syndrome in a subject that includes administering an effective amount of cannabidiol to the subject such that one or more symptoms of Fragile X Syndrome are treated.
(FR) La présente technologie concerne une méthode de traitement d'un ou de plusieurs symptômes du syndrome de l'X fragile à méthylation complète (Fmet) chez un sujet qui consiste à administrer une quantité efficace de cannabidiol au sujet de façon à traiter un ou plusieurs symptômes du syndrome de l'X fragile.
Latest bibliographic data on file with the International Bureau